Cathie Wood's ARK Invest Buys Over 380,000 Shares of Pfizer

Investing

Published: September 2, 2021 7:05 am

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 380,000 shares of Pfizer Inc. (NYSE: PFE) on Wednesday, as the price of this fund was up over 1% in the day’s session. It is also up a fair amount in the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 382,231 shares of Pfizer. At Wednesday’s closing price, this would have valued this purchase at roughly $17.6 million. This is only a small fraction of the total holdings. The fund is up about 42% over the past 52 weeks.

Check out all the ARK Invest buys for Wednesday:

Fund	Ticker	Name	Shares
ARKF	TDOC	TELADOC HEALTH	16,089
ARKF	Z	ZILLOW	2,688
ARKG	RPTX	REPARE THERAPEUTICS	3,200
ARKG	PSNL	PERSONALIS	3,781
ARKG	PFE	PFIZER	382,231
ARKG	NVTA	INVITAE	12,514
ARKG	ADPT	ADAPTIVE BIOTECHNOLOGIES	800
ARKK	FATE	FATE THERAPEUTICS	1,075
ARKK	SGFY	SIGNIFY HEALTH	189,960
ARKQ	ACIC	ATLAS CREST INVESTMENT	144,000
ARKQ	BLDE	BLADE AIR MOBILITY	36,482
ARKQ	SPFR	JAWS SPITFIRE ACQUISITION	14,879
ARKQ	KMTUY	KOMATSU	103,400
ARKQ	KTOS	KRATOS DEFENSE & SECURITY SOLUTIONS	41,408
ARKQ	MKFG	MARKFORGED	56,216
ARKW	GENI	GENIUS SPORTS	121,401
ARKX	6301JP	KOMATSU	62,800
ARKX	ACIC	ATLAS CREST INVESTMENT	31,000
ARKX	PRNT	3D PRINTING ETF	8,903

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

ALSO READ: The 2021 NFL Season Starts Next Week: 5 Champion Stocks Will Benefit

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?

Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.

Why wait? Click here to get started today!